<DOC>
	<DOCNO>NCT01414166</DOCNO>
	<brief_summary>The study evaluate use extend release niacin/laropiprant ( ERN/LRPT ) combination tablet primary prevention population currently take eligible lipid-modifying therapy ( LMT ) ; population comprise participant low moderate risk coronary heart disease ( CHD ) , low high density lipoprotein cholesterol ( HDL-C ) , low density lipoprotein cholesterol ( LDL-C ) goal level , normal mildly elevate triglyceride ( TG ) level .</brief_summary>
	<brief_title>Niacin/Laropiprant Tablet South Southeast Asians With Low High-Density Lipoprotein Cholesterol ( LDL-C ) Risk Cardiovascular Disease ( MK-0524A-108 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<criteria>Inclusion criterion : LMT ineligible Participants must meet lipid criterion `` low moderate CHD risk '' define National Cholesterol Education Program Adult Treatment Panel III Framingham Point Scores ( NCEP ATP III ) HDLC &lt; 40 mg/dL ( 1.03 mmol/L ) males &lt; 50 mg/dL ( 1.29 mmol/L ) females Triglyceride ( TG ) level &lt; 300 mg/dL ( 3.39 mmol/L ) . Fasting serum glucose ( FSG ) Visit 1 AND Visit 2 &lt; 126 mg/dL ( &lt; 7 mmol/L ) Hemoglobin A1c ( HbA1c ) level &lt; 6.5 % Participant willing use acceptable method contraception study , include 14day followup period Exclusion criterion : History malignancy ≤5 year prior sign inform consent , except adequatelytreated basal cell squamous cell skin cancer situ cervical cancer Participation study investigational compound ( nonlipidmodifying ) within 30 day Pregnant , breastfeeding , expect conceive , father child study , include 14day followup period Consumption 3 alcoholic drink give day 14 drink per week Engages plan engage vigorous exercise aggressive diet regimen study Diabetes mellitus , base medical history , FSG ≥126 mg/dL ( 7 mmol/L ) , HbA1c ≥6.5 % Risk factor coronary heart disease Active chronic hepatobiliary hepatic disease Active peptic ulcer disease within 3 month Visit 1 History hypersensitivity allergic reaction niacin niacincontaining product Episode gout within 1 year Visit 1 , unless currently stable allopurinol Taking LMT ( include statin , bile acid sequestrants , fibrates niacin &gt; 50 mg monotherapy coadministered LMTs ) Use overthe counter traditional medicine ( e.g . red yeast rice product ) lipidlowering Receiving treatment systemic corticosteroid ( unless stable therapy l 6 week replacement pituitary/adrenal/hypogonadal disease ) Uncontrolled illness infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>